4//SEC Filing
MANNINO RAPHAEL J 4
Accession 0000905718-18-000590
CIK 0001582554other
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 4:40 PM ET
Size
6.0 KB
Accession
0000905718-18-000590
Insider Transaction Report
Form 4
MANNINO RAPHAEL J
Chief Scientific Officer
Transactions
- Purchase
Series B Convertible Preferred Stock
2018-06-21$1000.00/sh+10$10,000→ 10 totalExercise: $0.50From: 2018-06-21→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]On June 21, 2018, the Reporting Person purchased 10 shares of Series B Convertible Preferred Stock from the Issuer in a public offering. Each share of Series B Convertible Preferred Stock is convertible into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock are convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate of Designations of Preferences, Rights and Limitations of Series B Preferred Stock of the Issuer. The Series B Convertible Preferred Stock has no expiration date.
Documents
Issuer
Matinas BioPharma Holdings, Inc.
CIK 0001582554
Entity typeother
Related Parties
1- filerCIK 0001196697
Filing Metadata
- Form type
- 4
- Filed
- Jun 21, 8:00 PM ET
- Accepted
- Jun 22, 4:40 PM ET
- Size
- 6.0 KB